Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 12Unknown 6Active not recruiting 4Recruiting 3Not yet recruiting 3Terminated 2Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 10Pancreatic Neoplasms 8Colorectal Neoplasms 8Rectal Neoplasms 7Neoplasm Metastasis 4Colorectal Cancer Metastatic 4Stomach Neoplasms 3Ovarian Neoplasms 3Colonic Neoplasms 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Gallbladder Neoplasms 2Carcinoma, Merkel Cell 2Biliary Tract Neoplasms 2Zollinger-Ellison Syndrome 1Vipoma 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Somatostatinoma 1Sarcoma 1Prostatic Neoplasms 1Pheochromocytoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Non functioning pancreatic endocrine tumor 1Neuroendocrine Tumors 1Neoplasms, Unknown Primary 1Multiple Endocrine Neoplasia Type 2b 1Multiple Endocrine Neoplasia Type 2a 1Multiple Endocrine Neoplasia Type 1 1

Interventions

Gemcitabine 6Cisplatin 5infigratinib 2Platinum 2Fluorouracil 21,2-diaminocyclohexaneplatinum II citrate 2ricolinostat 1niraparib 1lenvatinib 1galactomannan 1fludarabine 1famitinib 1dostarlimab 1atezolizumab 1aldesleukin 1Taxes 1Standard of Care 1Sildenafil Citrate 1Sevoflurane 1Photochemotherapy 1Oxaliplatin 1Observation 1NVP-BKM120 1Interviews as Topic 1IMC-001 1Electroporation 1Desflurane 1Cyclophosphamide 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Cholangiocarcinoma × Capecitabine × Clear all
NCT03117855 2017-04-18

Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by Surgery

City of Hope Medical Center

Phase 1 Withdrawn
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡